HIGHLIGHTS
- who: Invasiveness and colleagues from the Department of Medicine and Whitaker Cardiovascular Institute, Boston University School of Medicine, Boston, Massachusetts, United States of America have published the research work: DEspR Roles in Tumor Vasculo-Angiogenesis, Invasiveness, CSC-Survival and Anoikis Resistance: A ‘Common Receptor Coordinator’ Paradigm, in the Journal: PLOS ONE | www.plosone.org of January/21,/2014
- what: The authors show that functional analysis of the dual endothelin1/VEGFsignal peptide DEspR (formerly named Dear Chr.4q31.2) supports the putative common in pancreatic ductal adenocarcinoma (PDAC) and glioblastoma (GBM) selected for their CD133+CSCs . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.